215 related articles for article (PubMed ID: 24550007)
1. Screening with a novel cell-based assay for TAZ activators identifies a compound that enhances myogenesis in C2C12 cells and facilitates muscle repair in a muscle injury model.
Yang Z; Nakagawa K; Sarkar A; Maruyama J; Iwasa H; Bao Y; Ishigami-Yuasa M; Ito S; Kagechika H; Hata S; Nishina H; Abe S; Kitagawa M; Hata Y
Mol Cell Biol; 2014 May; 34(9):1607-21. PubMed ID: 24550007
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel compound that promotes myogenesis via Akt and transcriptional co-activator with PDZ-binding motif (TAZ) in mouse C2C12 cells.
Kodaka M; Mao F; Arimoto-Matsuzaki K; Kitamura M; Xu X; Yang Z; Nakagawa K; Maruyama J; Ishii K; Akazawa C; Oyaizu T; Yamamoto N; Ishigami-Yuasa M; Tsuemoto N; Ito S; Kagechika H; Nishina H; Hata Y
PLoS One; 2020; 15(4):e0231265. PubMed ID: 32267872
[TBL] [Abstract][Full Text] [Related]
3. A cell-based screening for TAZ activators identifies ethacridine, a widely used antiseptic and abortifacient, as a compound that promotes dephosphorylation of TAZ and inhibits adipogenesis in C3H10T1/2 cells.
Kawano S; Maruyama J; Nagashima S; Inami K; Qiu W; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
J Biochem; 2015 Nov; 158(5):413-23. PubMed ID: 25979969
[TBL] [Abstract][Full Text] [Related]
4. TAZ Activator Is Involved in IL-10-Mediated Muscle Responses in an Animal Model of Traumatic Brain Injury.
Zou R; Li D; Wang G; Zhang M; Zhao Y; Yang Z
Inflammation; 2017 Feb; 40(1):100-105. PubMed ID: 27718096
[TBL] [Abstract][Full Text] [Related]
5. TAZ as a novel enhancer of MyoD-mediated myogenic differentiation.
Jeong H; Bae S; An SY; Byun MR; Hwang JH; Yaffe MB; Hong JH; Hwang ES
FASEB J; 2010 Sep; 24(9):3310-20. PubMed ID: 20466877
[TBL] [Abstract][Full Text] [Related]
6. A new cell-based assay to evaluate myogenesis in mouse myoblast C2C12 cells.
Kodaka M; Yang Z; Nakagawa K; Maruyama J; Xu X; Sarkar A; Ichimura A; Nasu Y; Ozawa T; Iwasa H; Ishigami-Yuasa M; Ito S; Kagechika H; Hata Y
Exp Cell Res; 2015 Aug; 336(2):171-81. PubMed ID: 26116467
[TBL] [Abstract][Full Text] [Related]
7. Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif.
Nagashima S; Maruyama J; Kawano S; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
Cancer Sci; 2016 Jun; 107(6):791-802. PubMed ID: 27009852
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate stimulates myogenic differentiation through TAZ activation.
Kim AR; Kim KM; Byun MR; Hwang JH; Park JI; Oh HT; Jeong MG; Hwang ES; Hong JH
Biochem Biophys Res Commun; 2017 Apr; 486(2):378-384. PubMed ID: 28315325
[TBL] [Abstract][Full Text] [Related]
9. Bakuchiol augments MyoD activation leading to enhanced myoblast differentiation.
Lee SJ; Yoo M; Go GY; Kim DH; Choi H; Leem YE; Kim YK; Seo DW; Ryu JH; Kang JS; Bae GU
Chem Biol Interact; 2016 Mar; 248():60-7. PubMed ID: 26902638
[TBL] [Abstract][Full Text] [Related]
10. Novel TAZ modulators enhance myogenic differentiation and muscle regeneration.
Park GH; Jeong H; Jeong MG; Jang EJ; Bae MA; Lee YL; Kim NJ; Hong JH; Hwang ES
Br J Pharmacol; 2014 Sep; 171(17):4051-61. PubMed ID: 24821191
[TBL] [Abstract][Full Text] [Related]
11. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
[TBL] [Abstract][Full Text] [Related]
12. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
13.
Hitachi K; Nakatani M; Takasaki A; Ouchi Y; Uezumi A; Ageta H; Inagaki H; Kurahashi H; Tsuchida K
EMBO Rep; 2019 Mar; 20(3):. PubMed ID: 30622218
[TBL] [Abstract][Full Text] [Related]
14. MiR-96-5p Induced by Palmitic Acid Suppresses the Myogenic Differentiation of C2C12 Myoblasts by Targeting FHL1.
Nguyen MT; Min KH; Lee W
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322515
[TBL] [Abstract][Full Text] [Related]
15. Selenoprotein W enhances skeletal muscle differentiation by inhibiting TAZ binding to 14-3-3 protein.
Jeon YH; Park YH; Lee JH; Hong JH; Kim IY
Biochim Biophys Acta; 2014 Jul; 1843(7):1356-64. PubMed ID: 24726955
[TBL] [Abstract][Full Text] [Related]
16. Pask integrates hormonal signaling with histone modification via Wdr5 phosphorylation to drive myogenesis.
Kikani CK; Wu X; Paul L; Sabic H; Shen Z; Shakya A; Keefe A; Villanueva C; Kardon G; Graves B; Tantin D; Rutter J
Elife; 2016 Sep; 5():. PubMed ID: 27661449
[TBL] [Abstract][Full Text] [Related]
17. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program.
Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK
Skelet Muscle; 2016; 6():28. PubMed ID: 27551368
[TBL] [Abstract][Full Text] [Related]
18. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression.
Langley B; Thomas M; Bishop A; Sharma M; Gilmour S; Kambadur R
J Biol Chem; 2002 Dec; 277(51):49831-40. PubMed ID: 12244043
[TBL] [Abstract][Full Text] [Related]
19. Tip60 regulates myoblast differentiation by enhancing the transcriptional activity of MyoD via their physical interactions.
Kim JW; Jang SM; Kim CH; An JH; Kang EJ; Choi KH
FEBS J; 2011 Nov; 278(22):4394-404. PubMed ID: 21936881
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydropalmatine promotes myoblast differentiation through activation of p38MAPK and MyoD.
Lee SJ; Yoo M; Go GY; Hwang J; Lee HG; Kim YK; Seo DW; Baek NI; Ryu JH; Kang JS; Bae GU
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):147-52. PubMed ID: 25450677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
